| Primary information |
|---|
| ID | 13491 |
| Uniprot ID | Q90Y12 |
| Description | Bradykinin potentiating and C-type natriuretic peptides (BPP-CNP) [Cleaved into- Bradykinin-potentiating peptide Cdt1a; Bradykinin-potentiating peptide Cdt1b; Bradykinin-potentiating peptide Cdt2; Bradykinin inhibitor peptide Cdt3; C-type natriuretic peptide (CNP)] |
| Organism | Crotalus durissus terrificus |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria (diapsids); Lepidosauria (lepidosaurs); Squamata (squamates); Bifurcata (split-tongued squamates); Unidentata; Episquamata; Toxicofera; Serpentes (snakes); Colubroidea; Viperidae; Crotalinae (pit vipers); Crotalus; Crotalus durissus (tropical rattlesnake); Cro |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | In the N-terminal section; belongs to the bradykinin-potentiating peptide family. |
| Tissue Specificity | Venom gland. |
| Post Translational Modification | NA |
| Function | Bradykinin-potentiating peptide both inhibits the activity of the angiotensin-converting enzyme (ACE) and enhances the action of bradykinin by inhibiting the peptidases that inactivate it. It acts as an indirect hypotensive agent. Synthetic Cdt1a; Cdt1b and the short hexapeptide Cdt3 are able to potentiate the hypotensive effect mediated by Bk on the blood pressure of anesthetized rats. |
| Length | 181 |
| Molecular Weight | 18 |
| Name | NA |
| Sequence | NA |
| Sequence map | NA |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|